Availability: Strong medicine | Technische Universität München

Strong medicine: creating incentives for pharmaceutical research on neglected diseases

Saved in:

Bibliographic Details
Main Authors:	Kremer, Michael 1964- (Author), Glennerster, Rachel 1965- (Author)
Format:	Book
Language:	English
Published:	Princeton and Oxfordshire Princeton University Press [2004]
Subjects:	Farmaceutische industrie Keuzes Onderzoek Entwicklungsländer Pharmacy > Research > Economic aspects > Developing countries Drugs > Research > Economic aspects > Developing countries Vaccines > Research > Economic aspects > Developing countries Forschungsfinanzierung Gesundheitsförderung Forschungsförderung Arzneimittelforschung
Links:	http://www.loc.gov/catdir/bios/prin051/2004050384.html http://www.loc.gov/catdir/description/prin051/2004050384.html
Item Description:	Literaturverzeichnis Seite [127]-143, hier auch unveränderte Nachdrucke, published in paperback 2016
Physical Description:	xiv, 153 Seiten Diagramme
ISBN:	0691121133 9780691171166

Staff View

MARC


LEADER	00000nam a2200000 c 4500
001	BV019755980
003	DE-604
005	20250226
007	t\|
008	050401s2004 xxu\|\|\|\| \|\|\|\| 00\|\|\| eng d
010			\|a 2004050384
020			\|a 0691121133 \|c hardcover \|9 0-691-12113-3
020			\|a 9780691171166 \|c paperback \|9 978-0-691-17116-6
035			\|a (OCoLC)55596208
035			\|a (DE-599)BVBBV019755980
040			\|a DE-604 \|b ger \|e aacr
041	0		\|a eng
044			\|a xxu \|c US
049			\|a DE-12 \|a DE-703 \|a DE-M382 \|a DE-11
050		0	\|a RS122
082	0		\|a 362.17/82/091724 \|2 22
084			\|a VS 5350 \|0 (DE-625)147687:253 \|2 rvk
084			\|a PJ 2880 \|0 (DE-625)136694: \|2 rvk
100	1		\|a Kremer, Michael \|d 1964- \|0 (DE-588)128650532 \|4 aut
245	1	0	\|a Strong medicine \|b creating incentives for pharmaceutical research on neglected diseases \|c Michael Kremer and Rachel Glennerster
264		1	\|a Princeton and Oxfordshire \|b Princeton University Press \|c [2004]
264		4	\|c © 2004
300			\|a xiv, 153 Seiten \|b Diagramme
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
500			\|a Literaturverzeichnis Seite [127]-143, hier auch unveränderte Nachdrucke, published in paperback 2016
650		7	\|a Farmaceutische industrie \|2 gtt
650		7	\|a Keuzes \|2 gtt
650		7	\|a Onderzoek \|2 gtt
650		4	\|a Entwicklungsländer
650		4	\|a Pharmacy \|x Research \|x Economic aspects \|z Developing countries
650		4	\|a Drugs \|x Research \|x Economic aspects \|z Developing countries
650		4	\|a Vaccines \|x Research \|x Economic aspects \|z Developing countries
650	0	7	\|a Forschungsfinanzierung \|0 (DE-588)4155044-4 \|2 gnd \|9 rswk-swf
650	0	7	\|a Gesundheitsförderung \|0 (DE-588)4294611-6 \|2 gnd \|9 rswk-swf
650	0	7	\|a Forschungsförderung \|0 (DE-588)4125049-7 \|2 gnd \|9 rswk-swf
650	0	7	\|a Arzneimittelforschung \|0 (DE-588)4003120-2 \|2 gnd \|9 rswk-swf
651		7	\|a Entwicklungsländer \|0 (DE-588)4014954-7 \|2 gnd \|9 rswk-swf
689	0	0	\|a Entwicklungsländer \|0 (DE-588)4014954-7 \|D g
689	0	1	\|a Gesundheitsförderung \|0 (DE-588)4294611-6 \|D s
689	0	2	\|a Arzneimittelforschung \|0 (DE-588)4003120-2 \|D s
689	0	3	\|a Forschungsförderung \|0 (DE-588)4125049-7 \|D s
689	0		\|5 DE-604
689	1	0	\|a Entwicklungsländer \|0 (DE-588)4014954-7 \|D g
689	1	1	\|a Gesundheitsförderung \|0 (DE-588)4294611-6 \|D s
689	1	2	\|a Arzneimittelforschung \|0 (DE-588)4003120-2 \|D s
689	1	3	\|a Forschungsfinanzierung \|0 (DE-588)4155044-4 \|D s
689	1		\|C b \|5 DE-604
700	1		\|a Glennerster, Rachel \|d 1965- \|0 (DE-588)130514845 \|4 aut
856	4		\|u http://www.loc.gov/catdir/bios/prin051/2004050384.html \|3 Contributor biographical information
856	4		\|u http://www.loc.gov/catdir/description/prin051/2004050384.html \|3 Publisher description
943	1		\|a oai:aleph.bib-bvb.de:BVB01-013082445

Record in the Search Index

_version_	1825125074985811968
adam_text
any_adam_object
author	Kremer, Michael 1964- Glennerster, Rachel 1965-
author_GND	(DE-588)128650532 (DE-588)130514845
author_facet	Kremer, Michael 1964- Glennerster, Rachel 1965-
author_role	aut aut
author_sort	Kremer, Michael 1964-
author_variant	m k mk r g rg
building	Verbundindex
bvnumber	BV019755980
callnumber-first	R - Medicine
callnumber-label	RS122
callnumber-raw	RS122
callnumber-search	RS122
callnumber-sort	RS 3122
callnumber-subject	RS - Pharmacy
classification_rvk	VS 5350 PJ 2880
ctrlnum	(OCoLC)55596208 (DE-599)BVBBV019755980
dewey-full	362.17/82/091724
dewey-hundreds	300 - Social sciences
dewey-ones	362 - Social problems and services to groups
dewey-raw	362.17/82/091724
dewey-search	362.17/82/091724
dewey-sort	3362.17 282 591724
dewey-tens	360 - Social problems and services; associations
discipline	Chemie / Pharmazie Rechtswissenschaft Soziologie
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV019755980</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20250226</controlfield><controlfield tag="007">t\|</controlfield><controlfield tag="008">050401s2004 xxu\|\|\|\| \|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2004050384</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0691121133</subfield><subfield code="c">hardcover</subfield><subfield code="9">0-691-12113-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780691171166</subfield><subfield code="c">paperback</subfield><subfield code="9">978-0-691-17116-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)55596208</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019755980</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-M382</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS122</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.17/82/091724</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PJ 2880</subfield><subfield code="0">(DE-625)136694:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kremer, Michael</subfield><subfield code="d">1964-</subfield><subfield code="0">(DE-588)128650532</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Strong medicine</subfield><subfield code="b">creating incentives for pharmaceutical research on neglected diseases</subfield><subfield code="c">Michael Kremer and Rachel Glennerster</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Princeton and Oxfordshire</subfield><subfield code="b">Princeton University Press</subfield><subfield code="c">[2004]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 153 Seiten</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverzeichnis Seite [127]-143, hier auch unveränderte Nachdrucke, published in paperback 2016</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmaceutische industrie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Keuzes</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Onderzoek</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Entwicklungsländer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield><subfield code="x">Research</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield><subfield code="x">Research</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschungsfinanzierung</subfield><subfield code="0">(DE-588)4155044-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsförderung</subfield><subfield code="0">(DE-588)4294611-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschungsförderung</subfield><subfield code="0">(DE-588)4125049-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gesundheitsförderung</subfield><subfield code="0">(DE-588)4294611-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Forschungsförderung</subfield><subfield code="0">(DE-588)4125049-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Gesundheitsförderung</subfield><subfield code="0">(DE-588)4294611-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Forschungsfinanzierung</subfield><subfield code="0">(DE-588)4155044-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Glennerster, Rachel</subfield><subfield code="d">1965-</subfield><subfield code="0">(DE-588)130514845</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/bios/prin051/2004050384.html</subfield><subfield code="3">Contributor biographical information</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/description/prin051/2004050384.html</subfield><subfield code="3">Publisher description</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-013082445</subfield></datafield></record></collection>
geographic	Entwicklungsländer (DE-588)4014954-7 gnd
geographic_facet	Entwicklungsländer
id	DE-604.BV019755980
illustrated	Not Illustrated
indexdate	2025-02-26T13:01:48Z
institution	BVB
isbn	0691121133 9780691171166
language	English
lccn	2004050384
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-013082445
oclc_num	55596208
open_access_boolean
owner	DE-12 DE-703 DE-M382 DE-11
owner_facet	DE-12 DE-703 DE-M382 DE-11
physical	xiv, 153 Seiten Diagramme
publishDate	2004
publishDateSearch	2004
publishDateSort	2004
publisher	Princeton University Press
record_format	marc
spelling	Kremer, Michael 1964- (DE-588)128650532 aut Strong medicine creating incentives for pharmaceutical research on neglected diseases Michael Kremer and Rachel Glennerster Princeton and Oxfordshire Princeton University Press [2004] © 2004 xiv, 153 Seiten Diagramme txt rdacontent n rdamedia nc rdacarrier Literaturverzeichnis Seite [127]-143, hier auch unveränderte Nachdrucke, published in paperback 2016 Farmaceutische industrie gtt Keuzes gtt Onderzoek gtt Entwicklungsländer Pharmacy Research Economic aspects Developing countries Drugs Research Economic aspects Developing countries Vaccines Research Economic aspects Developing countries Forschungsfinanzierung (DE-588)4155044-4 gnd rswk-swf Gesundheitsförderung (DE-588)4294611-6 gnd rswk-swf Forschungsförderung (DE-588)4125049-7 gnd rswk-swf Arzneimittelforschung (DE-588)4003120-2 gnd rswk-swf Entwicklungsländer (DE-588)4014954-7 gnd rswk-swf Entwicklungsländer (DE-588)4014954-7 g Gesundheitsförderung (DE-588)4294611-6 s Arzneimittelforschung (DE-588)4003120-2 s Forschungsförderung (DE-588)4125049-7 s DE-604 Forschungsfinanzierung (DE-588)4155044-4 s b DE-604 Glennerster, Rachel 1965- (DE-588)130514845 aut http://www.loc.gov/catdir/bios/prin051/2004050384.html Contributor biographical information http://www.loc.gov/catdir/description/prin051/2004050384.html Publisher description
spellingShingle	Kremer, Michael 1964- Glennerster, Rachel 1965- Strong medicine creating incentives for pharmaceutical research on neglected diseases Farmaceutische industrie gtt Keuzes gtt Onderzoek gtt Entwicklungsländer Pharmacy Research Economic aspects Developing countries Drugs Research Economic aspects Developing countries Vaccines Research Economic aspects Developing countries Forschungsfinanzierung (DE-588)4155044-4 gnd Gesundheitsförderung (DE-588)4294611-6 gnd Forschungsförderung (DE-588)4125049-7 gnd Arzneimittelforschung (DE-588)4003120-2 gnd
subject_GND	(DE-588)4155044-4 (DE-588)4294611-6 (DE-588)4125049-7 (DE-588)4003120-2 (DE-588)4014954-7
title	Strong medicine creating incentives for pharmaceutical research on neglected diseases
title_auth	Strong medicine creating incentives for pharmaceutical research on neglected diseases
title_exact_search	Strong medicine creating incentives for pharmaceutical research on neglected diseases
title_full	Strong medicine creating incentives for pharmaceutical research on neglected diseases Michael Kremer and Rachel Glennerster
title_fullStr	Strong medicine creating incentives for pharmaceutical research on neglected diseases Michael Kremer and Rachel Glennerster
title_full_unstemmed	Strong medicine creating incentives for pharmaceutical research on neglected diseases Michael Kremer and Rachel Glennerster
title_short	Strong medicine
title_sort	strong medicine creating incentives for pharmaceutical research on neglected diseases
title_sub	creating incentives for pharmaceutical research on neglected diseases
topic	Farmaceutische industrie gtt Keuzes gtt Onderzoek gtt Entwicklungsländer Pharmacy Research Economic aspects Developing countries Drugs Research Economic aspects Developing countries Vaccines Research Economic aspects Developing countries Forschungsfinanzierung (DE-588)4155044-4 gnd Gesundheitsförderung (DE-588)4294611-6 gnd Forschungsförderung (DE-588)4125049-7 gnd Arzneimittelforschung (DE-588)4003120-2 gnd
topic_facet	Farmaceutische industrie Keuzes Onderzoek Entwicklungsländer Pharmacy Research Economic aspects Developing countries Drugs Research Economic aspects Developing countries Vaccines Research Economic aspects Developing countries Forschungsfinanzierung Gesundheitsförderung Forschungsförderung Arzneimittelforschung
url	http://www.loc.gov/catdir/bios/prin051/2004050384.html http://www.loc.gov/catdir/description/prin051/2004050384.html
work_keys_str_mv	AT kremermichael strongmedicinecreatingincentivesforpharmaceuticalresearchonneglecteddiseases AT glennersterrachel strongmedicinecreatingincentivesforpharmaceuticalresearchonneglecteddiseases

Availability

‌

Order via interlibrary loan